About: The Role of Anticoagulation in COVID-19-Induced Hypercoagulability

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Role of Anticoagulation in COVID-19-Induced Hypercoagulability Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
Creator	Ahmadian-Tehrani, Ashkan Anderson, Allen Chilton, Robert Rosas, Daniel White, Averi Simon, Juan
Source	Medline; PMC
abstract	PURPOSE OF REVIEW: We aim to provide a comprehensive analysis of hypercoagulability in individuals affected by COVID-19. Our goal is to describe the hypercoagulable state related to the infection and provide guidance regarding the possible benefits of anti-coagulation with the support of evidence from current literature. RECENT FINDINGS: The incidence of thrombotic disease in individuals affected by COVID-19 is reported as high as 31%. A significant mortality benefit has been observed with the use of therapeutic anticoagulation in high-risk individuals. Literature supports the use of scoring systems, such as the sepsis-induced coagulopathy score, to risk-stratify individuals who might benefit from anticoagulation. SUMMARY: COVID-19-induced hypercoagulability has been demonstrated to play a significant role in overall COVID-19 outcomes. Current literature shows promising evidence with the use of therapeutic anticoagulation in high-risk individuals. Further studies are needed to better analyze the risks and benefits of anticoagulation in this specific patient population.
has issue date	2020-06-17(xsd:dateTime)
bibo:doi	10.1007/s11886-020-01328-8
bibo:pmid	32556892
has license	no-cc
sha1sum (hex)	ae20e4ff3dd95cac0534ca22ccafc75d446022bb
schema:url	https://doi.org/10.1007/s11886-020-01328-8
resource representing a document's title	The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
has PubMed Central identifier	PMC7298694
has PubMed identifier	32556892
schema:publication	Curr Cardiol Rep
resource representing a document's body	covid:ae20e4ff3dd95cac0534ca22ccafc75d446022bb#body_text
is schema:about of	named entity 'RELATED' named entity 'hypercoagulability' named entity 'Hypercoagulability' named entity 'COVID-19' named entity 'disseminated intravascular coagulation' named entity 'thrombin' named entity 'platelet aggregation' named entity 'D-dimer' named entity 'COVID' named entity 'cytokine' named entity 'thrombosis' named entity 'COVID' named entity 'COVID' named entity 'FGF' named entity 'hypercoagulable state' named entity 'organ failure' named entity 'tumor necrosis factor' named entity 'prognosis' named entity 'ARDS' named entity 'LMWH' named entity 'transmembrane serine protease 2' named entity 'pneumonia' named entity 'bronchoalveolar lavage' named entity 'coagulopathy' named entity 'D-Dimer' named entity 'New England Journal of Medicine' named entity 'Italian' named entity 'hypercoagulability' named entity 'lungs' named entity 'thrombosis' named entity 'chemotaxis' named entity 'sepsis' named entity 'LMWH' named entity 'fibrin' named entity 'platelets' named entity 'anticardiolipin' named entity 'thrombin' named entity 'comorbidities' named entity 'D-dimer' named entity 'ACE2 receptor' named entity 'SERPIN' named entity 'SARS-CoV-2' named entity 'infectious disease' named entity 'SARS-CoV-1' named entity 'COVID' named entity 'COVID' named entity 'positively charged' named entity 'protein' named entity 'enoxaparin' named entity 'SIC' named entity 'serum' named entity 'plasmin' named entity 'viral particles' named entity 'infectivity' named entity 'IL-6' named entity 'prospective studies' named entity 'Coagulation cascade' named entity 'Thromboxane' named entity 'infection' named entity 'metaanalysis' named entity 'TLR9' named entity 'SARS-CoV-2' named entity 'serum' named entity 'SERPIN' named entity 'ultrasound' named entity 'leukocyte' named entity 'COVID-19' named entity 'inflammatory reaction' named entity 'Netherlands' named entity 'lung tissue' named entity 'ARDS' named entity 'heparin' named entity 'cytokines' named entity 'autopsies' named entity 'cytokine storm' named entity 'protease'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software